Edaravone Therapy
Edaravone Therapy is a pharmacotherapeutic intervention, belonging to the class of neuroprotective treatments, distinguished by its mechanism of action as a free radical scavenger specifically indicated to slow functional decline in patients with amyotrophic lateral sclerosis.
391
Publications
17.5K
Citations
2.4K
Authors
637
Institutions
Publications per year
2017–2026
160
391
Koji Abe, Yasuto Itoyama, Gen Sobue et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2014 · 360 citations · Full text
Medicine, Neurology, Pharmacotherapy +16
1–5 of 391
2.4K
10
h-index
9
h-index
7
h-index
7
h-index
6
h-index
1–5 of 2.4K
637

Okayama University
Okayama, Japan
16 h-index
148 publications
6.2K citations
Mitsubishi Tanabe Pharma Corporation
Osaka, Japan
13 h-index
37 publications
2K citations
Mitsubishi Corporation (United States)
New York, United States
11 h-index
37 publications
1.2K citations

Kagoshima University
Kagoshima, Japan
8 h-index
86 publications
3.3K citations
The University of Osaka
Osaka, Japan
7 h-index
36 publications
1.8K citations
Nippon Medical School
Tokyo, Japan
7 h-index
51 publications
1.9K citations
Army Medical University
Chongqing, China
6 h-index
43 publications
4.6K citations

Kōchi University
Kochi, Japan
6 h-index
26 publications
765 citations
1–8 of 637
EJP · 14 publications · 781 citations
13
h-index
13 publications · 790 citations
12
h-index
12 publications · 301 citations
11
h-index
10 publications · 337 citations
10
h-index
9 publications · 284 citations
10
h-index
1–5